Opentrons

What is Opentrons?

Opentrons is an investment fund that focuses on the intersection of technology and life sciences, providing lab automation solutions that are leveraged by laboratories worldwide. Their core products include the Opentrons Flex, Opentrons Flex Prep, and the OT-2 Workstations, accompanied by a range of pipettes, modules, and tips and labware designed to facilitate a wide variety of automated laboratory procedures.

The fund commits to making lab automation accessible with user-friendly software, extensive support systems, and modular designs that ensure laboratories can adapt effectively to the demands of cutting-edge research without undue financial burden. Opentrons' investment thesis centers on driving innovation through automation in fields like Next Generation Sequencing (NGS), nucleic acid extraction, PCR, protein purification, ELISA, and proteomics.

They support their partners and clients through an Automation Marketplace and provide educational resources, fostering a community of innovators. Opentrons maintains an extensive protocol library and offers no-code tools plus expert support to empower research endeavors.

The utilization of AI through OpentronsAI makes it possible to automate complex scientific discoveries, showcasing a commitment to democratizing biology and scaling scientific endeavors efficiently. Their minimum investment amount is $10,000, with a maximum of $50,000, and a sweet spot for investments at $25,000.

Opentrons specializes in providing pre-seed, seed, and series A funding, correlating with their focus on early-stage innovation in biotech, healthtech, medical devices, robotics, and healthcare industries.